Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-06-04Clinical Trial Update: Crizotinb or Standard Chemotherapy in Met Exon 14 Skipping Advanced NSCLC [Phase 2]
A Phase 2 trial tests crizotinib against standard chemotherapy in metastatic exon 14 skipping non-small cell lung cancer; the study is curre…
-
CLINICAL_TRIALS research · 2024-06-04Clinical Trial Update: Improvement of Personalized Lung Cancer Care Through Digital Connection and Patient Participation (DigiNet) [NA]
This clinical trial update describes the DigiNet study aimed at improving personalized lung cancer care through digital connectivity and pat…
-
CLINICAL_TRIALS research · 2024-06-03Clinical Trial Update: T-Cell Repertoire Sequencing: Assessing Pembrolizumab Efficacy in Advanced Non-small Lung Cancer [Phase 2]
A Phase 2 clinical trial is evaluating pembrolizumab efficacy in metastatic non-small cell lung cancer using T-cell repertoire sequencing; t…
-
CLINICAL_TRIALS research · 2024-05-31Clinical Trial Update: An Exploratory Study of Efficacy and Safety of Iruplinalkib Tablets in Patients With ROS1 Positive Non-small Cell Lung Cancer [EARLY_Phase 1]
An exploratory Phase 1 trial assessing the efficacy and safety of Iruplinalkib tablets in patients with ROS1-positive non-small cell lung ca…
-
CLINICAL_TRIALS research · 2024-05-30Clinical Trial Update: A Study of SBRT Combined With Puterizumab in Intrapulmonary Metastasis From NSCLC [Phase 2]
A Phase 2 clinical trial evaluating SBRT in combination with Puterizumab for intrapulmonary metastases from non-small-cell lung cancer, with…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-05-30Clinical Trial Update: Osimertinib and Etoposide as First-Line Treatment in Osimertinib-Resistant Advanced EGFR-Mutant NSCLC [Phase 2]
Phase 2 trial evaluating osimertinib plus etoposide as first-line therapy in osimertinib-resistant advanced EGFR-mutant non-small cell lung …
-
CLINICAL_TRIALS research · 2024-05-30Clinical Trial Update: Immune Treatment of Brain Metastasis of Lung Cancer Combined With Large-segmentation Precision Radiotherapy [Phase 2]
A Phase 2 clinical trial in non-small cell lung cancer with brain metastases is currently recruiting, evaluating an immune therapy in combin…
-
CLINICAL_TRIALS research · 2024-05-29Clinical Trial Update: Assessing an Oral EGFR Inhibitor, DZD9008 in Patients With Advanced Non-small Cell Lung Cancer(NSCLC) With EGFR Mutations (WU-KONG15) [NA]
Clinical trial update for DZD9008, an oral EGFR inhibitor, in patients with advanced non-small cell lung cancer with EGFR mutations. The stu…
-
CLINICAL_TRIALS research · 2024-05-28Clinical Trial Update: Safety and Efficacy of Whole Brain LDRT+ICI+Intrathecal Chemotherapy in Refractory Meningeal Metastasis of Lung Cancer [Phase 1]
A Phase 1 clinical trial update evaluating safety and efficacy of combining whole-brain low-dose radiotherapy with a PD-1 inhibitor and intr…
-
CLINICAL_TRIALS research · 2024-05-28Clinical Trial Update: a Single-arm, Single-center, Open Clinical Study
This update notes a single-arm, single-center, open-label clinical trial that is currently recruiting, evaluating treatment across multiple …
-
CLINICAL_TRIALS research · 2024-05-24Clinical Trial Update: Safety and Feasibility of Surgery After Conversion Therapy for Locally Advanced and Advanced NSCLC [NA]
Clinical trial update noting an ongoing study evaluating the safety and feasibility of surgery after conversion therapy for locally advanced…
-
CLINICAL_TRIALS research · 2024-05-23Clinical Trial Update: Value of Screening MRI Brain in Stage IV Non-small Cell Lung Cancer [NA]
This clinical trial update investigates the value of screening MRI brain in patients with stage IV non-small cell lung cancer (metastatic). …
-
CLINICAL_TRIALS research · 2024-05-22Clinical Trial Update: A Study Comparing Neoadjuvant Chemoimmunotherapy and Immuno-consolidationafter Compared With Immunoconsolidation After Radical Chemoradiotherapy for Stage III Potentially Resectable NSCLC [Phase 2]
A Phase 2 trial comparing neoadjuvant chemoimmunotherapy and immuno-consolidation after radical chemoradiotherapy for stage III potentially …
-
CLINICAL_TRIALS research · 2024-05-22Clinical Trial Update: Recurrent Predictive Power of Circulating Tumor Cells for Non Small Cell Lung Cancer Patients
This clinical trial update examines whether circulating tumor cells can predict recurrence in patients with non-small cell lung cancer.
-
CLINICAL_TRIALS research · 2024-05-22Clinical Trial Update: Cadonilimab Plus Chemotherapy as First-line Treatment for PD-L1 Negative NSCLC [Phase 2]
A Phase 2 trial is evaluating cadonilimab plus chemotherapy as first-line treatment for PD-L1 negative non-small cell lung cancer, with pati…
-
CLINICAL_TRIALS research · 2024-05-22Clinical Trial Update: Clinical Significance of Circulating Tumor Cell in Non Small Cell Lung Cancer
An update on a clinical trial evaluating the clinical significance of circulating tumor cells in non-small cell lung cancer. The current sta…
-
CLINICAL_TRIALS research · 2024-05-21Clinical Trial Update: A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating ILB2109 in combination with toripalimab in patients with advanced solid malignancies, currently recrui…
-
CLINICAL_TRIALS research · 2024-05-21Clinical Trial Update: A Prospective, Multicenter, Non-interventional, Real-world Study to Characterize Changes in Molecular Markers After Three Weeks of Targeted Therapy With Oxitinib in EGFRm NSCLC
This prospective, multicenter, non-interventional real-world study will characterize changes in molecular markers after three weeks of targe…
-
CLINICAL_TRIALS research · 2024-05-20Clinical Trial Update: A Prospective, Single-arm, Phase II Clinical Trial to Evaluate the Efficacy and Safety of Tafolecimab and Sintilimab Combined With Chemotherapy in Patients With Advanced or Metastatic Driver Gene-negative Non-small Cell Lung Cancer After Failure of First-line Immunotherapy. [Phase 2]
A prospective, single-arm Phase II trial evaluating Tafolecimab plus Sintilimab with chemotherapy in advanced or metastatic driver gene-nega…
-
CLINICAL_TRIALS research · 2024-05-17Clinical Trial Update: Observational Study of Afatinib 30 mg Daily
Observational study evaluating afatinib 30 mg daily for non-small cell lung cancer with EGFR mutation; currently recruiting at National Univ…
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: Use of the ADL-Glittre Test in the Pre and Postoperative Period of Patients With Lung Cancer [NA]
A clinical trial update evaluating the ADL-Glittre Test to measure activities of daily living in patients with non-small cell lung cancer du…
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: Predicting Response to Neoadjuvant ATEZOLIZUMAB Plus Carboplatin/Nab Paclitaxel in Resectable Non-squamous NSCLC [Phase 2]
A Phase 2 trial is evaluating whether combining atezolizumab with carboplatin and nab-paclitaxel as neoadjuvant therapy can predict response…
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: Surufatinib Combined With Tislelizumab in Advanced Lung Cancer With Neuroendocrine Differentiation [Phase 2]
A Phase 2 trial updating on the combination of surufatinib and tislelizumab for advanced non-small cell lung cancer with neuroendocrine diff…
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: A Phase II Study of SSGJ-707 Monotherapy in First-line PD-L1 Positive Advanced NSCLC Patients [Phase 2]
A Phase II study of SSGJ-707 as first-line monotherapy for PD-L1 positive advanced non-small cell lung cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2024-05-13Clinical Trial Update: Comparison of Standard Dose Alectinib to Alectinib in Adjusted Dose Based on Alectinib Bloodlevels [Phase 4]
A Phase 4 trial is comparing standard-dose alectinib to dose-adjusted dosing based on blood levels in ALK-positive non-small cell lung cance…